Neurology CME Courses

Neurology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and immune-related toxicities. Patient case studies are included to illustrate considerations in the selection and sequencing of therapy and the management of immune-related toxicities.
Finding Your Footing in the Shifting Landscape of Multiple Sclerosis

Finding Your Footing in the Shifting Landscape of Multiple Sclerosis | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, ANCC Contact Hour(s)
In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies. Expert faculty will review clinical data supporting the efficacy and safety of novel and emerging immune-directed therapies as well as the role of biomarkers in assessing disease progression and guiding treatment decisions in patients with MS.
PatientGPS™: Clinical Paths in the Preventive Treatment of Migraine

Clinical Paths in the Preventive Treatment of Migraine | myCME

AMA PRA Category 1 Credit(s)TM
This online, case-based activity explores advances and challenges in the care of patients with migraine from diagnosis through treatment. Topics discussed include strategies for differential diagnosis, recognition of medication overuse, and criteria for use of preventive therapy. In addition, our expert faculty describes advances in the understanding of migraine pathophysiology that have led to new treatments and reviews key clinical data to inform the appropriate use of these therapies.
BRAINWeekEnd: A 3-Part Review Addressing Management and Treatment Options for Relapsing Remitting MS, Schizophrenia, and Parkinson’s Disease

BRAINWeekEnd: A 3-Part Review Addressing Management and Treatment Options for Relapsing Remitting MS, Schizophrenia, and Parkinson’s Disease | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AANP Contact Hour(s), CE for Pharmacists
A rising geriatric population, increased life expectancy, and the anticipated launch of novel molecules are driving the need for continuing medical education for clinicians treating neurological disorders. This BRAINWeek Highlights activity presents three timely and relevant presentations focused on the most commonly diagnosed CNS conditions.
Racial and Genetic Implications for MS Treatment Selection

Racial and Genetic Implications for MS Treatment Selection

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
This online session will explore differences in the prevalence and incidence of Multiple Sclerosis based on gender and race, as well as the implications for treatment selection and management of side effects.
Applying Precision Medicine in MS: Educational Bites and Case Decision Library

Applying Precision Medicine in MS: Educational Bites and Case Decision Library

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
The treatment landscape for patients with multiple sclerosis (MS) has expanded significantly in the past 2 decades. As a result, clinicians have several disease‐modifying therapies (DMTs) to choose from when addressing the management needs of their patients with MS.
Optimizing Management of Myasthenia Gravis With Novel Targeted Therapy

Optimizing Management of Myasthenia Gravis With Novel Targeted Therapy | myCME

AMA PRA Category 1 Credit(s)TM
During this myCME ™ Expert Perspectives roundtable discussion, 3 distinguished faculty discuss new understandings of the immunologic processes involved in the development of myasthenia gravis (MG,) the novel agents that target these processes, and the most recent clinical evidence for efficacy and safety. The faculty will also discuss the potential advantages of newer agents over conventional MG agents.
Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies

Rethinking Routines in Multiple Sclerosis Management | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
This CME Outfitters webcast will feature an expert panel discussion that focuses on the efficacy and safety of recently approved DMTs, implementing cognitive assessment into routine monitoring for patients with MS, and emerging data on the effects of MS therapies on cognition.
When and How to Switch Therapies in MS: Neurology Guideline Implementation and Expert Recommendation

When and How to Switch Therapies in MS: Neurology Guideline Implementation and Expert Recommendation | myCME

AMA PRA Category 1 Credit(s)TM
Medications such as immunomodulatory and immunosuppressive disease-modifying therapies (DMTs) can delay this damage and slow the resulting progressive phase, thus helping maintain quality of life for patients with Multiple Sclerosis. To make an informed decision, clinicians need to understand the rationale behind medication choices and the risks and benefits of DMTs available.

Click for More Neurology Courses

Next hm-section-front in Neurology CME Courses